Resonant Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A3
- Latest Deal Amount
-
$2.54M
- Investors
-
6
Resonant Therapeutics General Information
Description
Developer of a drug discovery platform designed to help pharma clients expand their drug discovery pipeline. The company's platform focuses on the tumor microenvironment and data science to identify novel tumor-selective targets and anti-tumor antibodies, enabling researchers to identify and accelerate therapeutic and target discovery against cancers.
Contact Information
Website
www.resonantrx.comCorporate Office
- 2450 Holcombe Boulevard
- Suite J
- Houston, TX 77021
- United States
Corporate Office
- 2450 Holcombe Boulevard
- Suite J
- Houston, TX 77021
- United States
Resonant Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A3) | 28-Oct-2021 | $2.54M | Completed | Pre-Clinical Trials | ||
| 4. Early Stage VC (Series A2) | 31-Jul-2017 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 02-Mar-2016 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2016 | $1.6M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC (Series A) | 15-Oct-2015 | $1.6M | $1.6M | Completed | Startup |
Resonant Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A | 453,328 | $0.001000 | $0.37 | $4.65 | $4.65 | 1x | $4.65 | 25.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Resonant Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Resonant Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Resonant Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Texas Halo Fund | Venture Capital | Minority | ||
| Urban Capital Network | Venture Capital | Minority | ||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | Minority | ||
| Innovation Partnerships | Venture Capital | Minority | ||
| Mercury Fund | Venture Capital | Minority |
Resonant Therapeutics FAQs
-
When was Resonant Therapeutics founded?
Resonant Therapeutics was founded in 2014.
-
Where is Resonant Therapeutics headquartered?
Resonant Therapeutics is headquartered in Houston, TX.
-
What is the size of Resonant Therapeutics?
Resonant Therapeutics has 5 total employees.
-
What industry is Resonant Therapeutics in?
Resonant Therapeutics’s primary industry is Drug Discovery.
-
Is Resonant Therapeutics a private or public company?
Resonant Therapeutics is a Private company.
-
What is the current valuation of Resonant Therapeutics?
The current valuation of Resonant Therapeutics is .
-
What is Resonant Therapeutics’s current revenue?
The current revenue for Resonant Therapeutics is .
-
How much funding has Resonant Therapeutics raised over time?
Resonant Therapeutics has raised $6.14M.
-
Who are Resonant Therapeutics’s investors?
Texas Halo Fund, Urban Capital Network, Johnson & Johnson Innovation - JLABS, Innovation Partnerships, and Mercury Fund are 5 of 6 investors who have invested in Resonant Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
